Illustrated pathology of the bone marrow
暂无分享,去创建一个
[1] Mycosis Fungoides and Sezary Syndrome , 2020, Definitions.
[2] G. Vadlamudi,et al. The use of monoclonal antibody R92F6 and polymerase chain reaction to confirm the presence of parvovirus B19 in bone marrow specimens of patients with acquired immunodeficiency syndrome. , 2009, Archives of pathology & laboratory medicine.
[3] M. Werner,et al. Myelofibrosis in primary myelodysplastic syndromes: a retrospective study of 352 patients. , 2009, European journal of haematology.
[4] I. Magrath,et al. Bone marrow involvement in young patients with non-Hodgkin's lymphoma: the importance of multiple bone marrow samples for accurate staging. , 2006, Medical and pediatric oncology.
[5] P. Banks,et al. Acute panmyelosis with myelofibrosis: an entity distinct from acute megakaryoblastic leukemia , 2005, Modern Pathology.
[6] R. Siebert,et al. Variable frequencies of MALT lymphoma-associated genetic aberrations in MALT lymphomas of different sites , 2004, Leukemia.
[7] A. Tefferi,et al. Bone marrow mast cell immunophenotyping in adults with mast cell disease: a prospective study of 33 patients. , 2004, Leukemia research.
[8] K. Sotlar,et al. Systemic mastocytosis with associated clonal haematological non-mast cell lineage diseases: a histopathological challenge , 2004, Journal of Clinical Pathology.
[9] G. Pinkus,et al. CD138 (Syndecan-1), a Plasma Cell Marker , 2004 .
[10] G. Pinkus,et al. CD138 (syndecan-1), a plasma cell marker immunohistochemical profile in hematopoietic and nonhematopoietic neoplasms. , 2004, American journal of clinical pathology.
[11] C. Bloomfield,et al. Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] A. Manabe,et al. Third International Symposium on Myelodysplastic Syndromes in Childhood , 2003 .
[13] D. Arber,et al. Pathology of the myeloproliferative diseases. , 2003, Hematology/oncology clinics of North America.
[14] M. Skinner,et al. Bone marrow core biopsy specimens in AL (primary) amyloidosis. A morphologic and immunohistochemical study of 100 cases. , 2003, American journal of clinical pathology.
[15] M. Skinner,et al. Bone Marrow Core Biopsy Specimens in AL (Primary) Amyloidosis , 2003 .
[16] K. Chang,et al. Histiocytic lesions involving the bone marrow. , 2003, Seminars in diagnostic pathology.
[17] A. Tefferi,et al. Flt-3 and c-kit mutation studies in a spectrum of chronic myeloid disorders including systemic mast cell disease. , 2003, Leukemia research.
[18] P. Chu,et al. Expression of T/NK-cell and plasma cell antigens in nonhematopoietic epithelioid neoplasms. An immunohistochemical study of 447 cases. , 2003, American journal of clinical pathology.
[19] A. Tefferi,et al. Chronic basophilic leukemia: a distinct clinico‐pathologic entity? , 2003, European journal of haematology.
[20] M. Slovak,et al. High frequency of pro-B acute lymphoblastic leukemia in adults with secondary leukemia with 11q23 abnormalities , 2003, Leukemia.
[21] M. Rue,et al. Clinical and biologic implications of recurrent genomic aberrations in myeloma. , 2003, Blood.
[22] M. Slovak,et al. Value of combined morphologic, cytochemical, and immunophenotypic features in predicting recurrent cytogenetic abnormalities in acute myeloid leukemia. , 2003, Human pathology.
[23] H. Pahl. PRV-1 mRNA expression and other molecular markers in polycythemia rubra vera. , 2003, Current hematology reports.
[24] Emili Montserrat,et al. ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia. , 2003, The New England journal of medicine.
[25] S. Miyawaki,et al. Prevalence and clinical characteristics of myelodysplastic syndrome with bone marrow eosinophilia or basophilia. , 2003, Blood.
[26] M. Slovak,et al. Prognostic Impact of Acute Myeloid Leukemia Classification , 2003 .
[27] M. Slovak,et al. Prognostic impact of acute myeloid leukemia classification. Importance of detection of recurring cytogenetic abnormalities and multilineage dysplasia on survival. , 2003, American journal of clinical pathology.
[28] R. Gale. Pathogenic markers in essential thrombocythemia. , 2003, Current hematology reports.
[29] J. Benhattar,et al. Contribution of IgH-PCR to the evaluation of B-cell lymphoma involvement in paraffin-embedded bone marrow biopsy specimens. , 2003, American journal of clinical pathology.
[30] Peter Marynen,et al. A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome. , 2003, The New England journal of medicine.
[31] D. Catovsky,et al. The variant form of hairy-cell leukaemia. , 2003, Best practice & research. Clinical haematology.
[32] P. Brousset,et al. Intrasinusoidal bone marrow infiltration: a common growth pattern for different lymphoma subtypes , 2002, British journal of haematology.
[33] J. Melo,et al. Cytogenetic and Molecular Genetic Aspects of Chronic Myeloid Leukaemia , 2002, Acta Haematologica.
[34] E. Torlakovic,et al. Follicular pattern of bone marrow involvement by follicular lymphoma. , 2002, American journal of clinical pathology.
[35] S. Serrano,et al. Genetic characterization of the paraimmunoblastic variant of small lymphocytic lymphoma/chronic lymphocytic leukemia: A case report and review of the literature. , 2002, Human pathology.
[36] S. Paydaş,et al. Bone marrow necrosis: Clinicopathologic analysis of 20 cases and review of the literature , 2002, American journal of hematology.
[37] R. Braziel,et al. Hematopathologic and cytogenetic findings in imatinib mesylate-treated chronic myelogenous leukemia patients: 14 months' experience. , 2002, Blood.
[38] S. Rajkumar,et al. Diagnostic and prognostic value of bone marrow angiogenesis and megakaryocyte c-Mpl expression in essential thrombocythemia. , 2002, Blood.
[39] P. Chu,et al. Keratin expression in human tissues and neoplasms , 2002, Histopathology.
[40] J. Rowley,et al. International workshop on the relationship of prior therapy to balanced chromosome aberrations in therapy‐related myelodysplastic syndromes and acute leukemia: Overview report , 2002, Genes, chromosomes & cancer.
[41] K. Welte,et al. Kostmann syndrome and severe congenital neutropenia. , 2002, Seminars in hematology.
[42] M. Slovak,et al. Diagnostic utility of bilateral bone marrow examination , 2002, Cancer.
[43] I. Lampert,et al. ST1571 (imatinib mesylate) reduces bone marrow cellularity and normalizes morphologic features irrespective of cytogenetic response. , 2002, American journal of clinical pathology.
[44] N. Cross,et al. Myeloproliferative Disorders with Translocations of Chromosome 5q31–35: Role of the Platelet-Derived Growth Factor Receptor Beta , 2002, Acta Haematologica.
[45] M. Baccarani,et al. Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia. , 2002, The New England journal of medicine.
[46] Terry M Therneau,et al. A long-term study of prognosis in monoclonal gammopathy of undetermined significance. , 2002, The New England journal of medicine.
[47] J. Rowley,et al. Therapy-related acute myeloid leukemia/myelodysplasia with balanced 21q22 translocations. , 2002, American journal of clinical pathology.
[48] S. Kroft,et al. Assessment of CD10 in the diagnosis of small B-cell lymphomas: a multiparameter flow cytometric study. , 2002, American journal of clinical pathology.
[49] P. Chu,et al. Recurrent B-cell Neoplasms After Rituximab Therapy: An Immunophenotypic and Genotypic Study , 2002, Leukemia & lymphoma.
[50] D. Arber,et al. Angiotropic Lymphoma: An Immunophenotypically and Clinically Heterogeneous Lymphoma , 2001, Modern Pathology.
[51] T. Schwartz,et al. Association between Intracranial Plasmacytoma and Multiple Myeloma: Clinicopathological Outcome Study , 2001, Neurosurgery.
[52] L. Degos,et al. All trans retinoic acid in acute promyelocytic leukemia , 2001, Oncogene.
[53] B. Bain. Bone marrow trephine biopsy. , 2001, Journal of clinical pathology.
[54] C. Harrison,et al. Acute lymphoblastic leukaemia. , 2001, Best practice & research. Clinical haematology.
[55] B. Bain,et al. Bone marrow aspiration. , 2001, Journal of clinical pathology.
[56] D C Arthur,et al. Diagnostic utility of flow cytometric immunophenotyping in myelodysplastic syndrome. , 2001, Blood.
[57] R. Brynes,et al. Pathology of autoimmune myelofibrosis. A report of three cases and a review of the literature. , 2001, American journal of clinical pathology.
[58] J. Niland,et al. Myeloperoxidase immunoreactivity in adult acute lymphoblastic leukemia. , 2001, American journal of clinical pathology.
[59] L. Kass,et al. Perivascular Plasmacytosis: A Light-Microscopic and Immunohistochemical Study of 93 Bone Marrow Biopsies , 2001, Acta Haematologica.
[60] S. Pileri,et al. Iliac crest biopsy versus rib segment resection for the detection of bone marrow isolated tumor cells from lung and esophageal cancer. , 2001, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[61] D. Arber. Realistic pathologic classification of acute myeloid leukemias. , 2001, American journal of clinical pathology.
[62] L. Medeiros,et al. Mature B-cell leukemias with more than 55% prolymphocytes. A heterogeneous group that includes an unusual variant of mantle cell lymphoma. , 2001, American journal of clinical pathology.
[63] A. Órfão,et al. Adult precursor B-ALL with BCR/ABL gene rearrangements displays a unique immunophenotype based on the pattern of CD10, CD34, CD13 and CD38 expression , 2001, Leukemia.
[64] B. Swolin,et al. Masked monosomy 7 in myelodysplastic syndromes is uncommon and of undetermined clinical significance. , 2001, Leukemia research.
[65] R. Clementi,et al. Hemophagocytic lymphohistiocytosis due to germline mutations in SH2D1A, the X-linked lymphoproliferative disease gene. , 2001, Blood.
[66] R. Hutchison,et al. Apoptotic index by Annexin V flow cytometry: adjunct to morphologic and cytogenetic diagnosis of myelodysplastic syndromes. , 2001, Cytometry.
[67] C. Scriver,et al. The Metabolic and Molecular Bases of Inherited Disease, 8th Edition 2001 , 2001, Journal of Inherited Metabolic Disease.
[68] G. Buffone,et al. Cytochemical Staining and Flow Cytometry Methods Applied to the Diagnosis of Acute Leukemia in the Pediatric Population: An Assessment of Relative Usefulness , 2001, Journal of pediatric hematology/oncology.
[69] A. Chott,et al. Ineffectiveness of interferon-γ in the treatment of idiopathic myelofibrosis: a pilot study , 2001, Annals of Hematology.
[70] E. Ascari,et al. Expression of p53, Bcl-2 and Ras Oncoproteins and Apoptosis Levels in Acute Leukaemias and Myelodysplastic Syndromes , 2001, Leukemia & lymphoma.
[71] D. Arber,et al. Keratin Immunohistochemistry Detects Clinically Significant Metastases in Bone Marrow Biopsy Specimens in Women With Lobular Breast Carcinoma , 2000, The American journal of surgical pathology.
[72] U. Germing,et al. Validation of the WHO proposals for a new classification of primary myelodysplastic syndromes: a retrospective analysis of 1600 patients. , 2000, Leukemia research.
[73] T. Schulz,et al. Bone marrow failure associated with human herpesvirus 8 infection after transplantation. , 2000, The New England journal of medicine.
[74] D. Arber. Molecular diagnostic approach to non-Hodgkin's lymphoma. , 2000, The Journal of molecular diagnostics : JMD.
[75] D. Uçkan,et al. Acute parvovirus B19 infection mimicking juvenile myelomonocytic leukemia , 2000, European journal of haematology.
[76] E. Wattel,et al. Expression of the multidrug resistance‐associated protein in myelodysplastic syndromes , 2000, British journal of haematology.
[77] P. Chu,et al. Cytokeratin 7 and Cytokeratin 20 Expression in Epithelial Neoplasms: A Survey of 435 Cases , 2000, Modern Pathology.
[78] S. Richards,et al. Application of flow cytometry to the diagnosis of paroxysmal nocturnal hemoglobinuria. , 2000, Cytometry.
[79] F. Birg,et al. A new morphologic classification system for acute promyelocytic leukemia distinguishes cases with underlying PLZF/RARA gene rearrangements. , 2000, Blood.
[80] A. Órfão,et al. Quantitative multiparametric immunophenotyping in acute lymphoblastic leukemia: correlation with specific genotype. I. ETV6/AML1 ALLs identification , 2000, Leukemia.
[81] H. Kaufmann,et al. The biology of multiple myeloma , 2000, Journal of Cancer Research and Clinical Oncology.
[82] V. Diehl,et al. Effects of chemotherapy (busulfan-hydroxyurea) and interferon-alfa on bone marrow morphologic features in chronic myelogenous leukemia. Histochemical and morphometric study on sequential trephine biopsy specimens with special emphasis on dynamic features. , 2000, American journal of clinical pathology.
[83] M. Werner,et al. PCR analysis of IgH-gene rearrangements in small lymphoid infiltrates microdissected from sections of paraffin-embedded bone marrow biopsy specimens. , 2000, Human pathology.
[84] D. Christiansen,et al. Therapy-related acute myeloid leukemia and myelodysplasia after high-dose chemotherapy and autologous stem cell transplantation. , 2000, Blood.
[85] D. Heilman,et al. Immunohistochemistry can be used to subtype acute myeloid leukemia in routinely processed bone marrow biopsy specimens. Comparison with flow cytometry. , 2000, American journal of clinical pathology.
[86] D. Head,et al. Long‐term survival of infants with idiopathic myelofibrosis , 2000, British journal of haematology.
[87] D. Arber,et al. Paraffin section immunophenotype of cutaneous and extracutaneous mast cell disease: comparison to other hematopoietic neoplasms. , 2000, The American journal of surgical pathology.
[88] F. Offner,et al. Bone marrow necrosis , 2000, Cancer.
[89] D. Catovsky,et al. Frequent deletions at 11q23 and 13q14 in B cell prolymphocytic leukemia (B-PLL) , 2000, Leukemia.
[90] N. Fineberg,et al. Flow cytometric immunophenotypic characterization of pediatric and adult minimally differentiated acute myeloid leukemia (AML-M0). , 2000, American journal of clinical pathology.
[91] M. Jotterand,et al. CD34/QBEND10 immunostaining in bone marrow biopsies: an additional parameterfor the diagnosis and classification of myelodysplastic syndromes , 2000, European journal of haematology.
[92] T. Yoshizaki,et al. Elevation of antibody against Epstein-Barr virus genes BRLF1 and BZLF1 in nasopharyngeal carcinoma , 2000, Journal of Cancer Research and Clinical Oncology.
[93] A. Fischer,et al. Perforin gene defects in familial hemophagocytic lymphohistiocytosis. , 1999, Science.
[94] G. Pruneri,et al. Angiogenesis in myelodysplastic syndromes , 1999, British Journal of Cancer.
[95] G Flandrin,et al. The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. Report of the Clinical Advisory Committee meeting, Airlie House, Virginia, November, 1997. , 1999, Annals of oncology : official journal of the European Society for Medical Oncology.
[96] V. Diehl,et al. Initial (prefibrotic) stages of idiopathic (primary) myelofibrosis (IMF) – a clinicopathological study , 1999, Leukemia.
[97] N. Chiorazzi,et al. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. , 1999, Blood.
[98] T J Hamblin,et al. Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. , 1999, Blood.
[99] R. Green. Macrocytic and Marrow Failure Anemias , 1999 .
[100] M. Cleary,et al. MLL rearrangements in haematological malignancies: lessons from clinical and biological studies , 1999, British journal of haematology.
[101] K. Tobal,et al. Detection of minimal residual disease in acute myeloid leukaemia: methodologies, clinical and biological significance , 1999, British journal of haematology.
[102] M. Buckley,et al. The detection of mast cell subpopulations in formalin‐fixed human tissues using a new monoclonal antibody specific for chymase , 1999, The Journal of pathology.
[103] J. Downing. THE AML1‐ETO CHIMAERIC TRANSCRIPTION FACTOR IN ACUTE MYELOID LEUKAEMIA: BIOLOGY AND CLINICAL SIGNIFICANCE , 1999, British journal of haematology.
[104] N. Rosenthal,et al. Differential Diagnosis of Microcytic Anemias , 1999 .
[105] M. Pfeilstöcker,et al. Cross‐validation of prognostic scores in myelodysplastic syndromes on 386 patients from a single institution confirms importance of cytogenetics , 1999, British journal of haematology.
[106] N. Young. Acquired aplastic anemia. , 1999, Journal of the American Medical Association (JAMA).
[107] Cawley,et al. HAIRY‐CELL LEUKAEMIA: BIOLOGY AND MANAGEMENT , 1999, British journal of haematology.
[108] Powers Peterson,et al. Anemia: Pathophysiology, Clinical Features, and Laboratory Evaluation , 1999 .
[109] J. Chan,et al. Cytogenetic abnormalities in natural killer cell lymphoma/leukaemia--is there a consistent pattern? , 1999, Leukemia & lymphoma.
[110] C. Bloomfield,et al. Prospective karyotype analysis in adult acute lymphoblastic leukemia: the cancer and leukemia Group B experience. , 1999, Blood.
[111] P. Marynen,et al. The apoptosis inhibitor gene API2 and a novel 18q gene, MLT, are recurrently rearranged in the t(11;18)(q21;q21) associated with mucosa-associated lymphoid tissue lymphomas. , 1999, Blood.
[112] P. Griffiths,et al. HHV‐6‐related secondary graft failure following allogeneic bone marrow transplantation , 1999, British journal of haematology.
[113] Jonathan D. Licht,et al. Deconstructing a Disease: RAR, Its Fusion Partners, and Their Roles in the Pathogenesis of Acute Promyelocytic Leukemia , 1999 .
[114] M. Tomonaga,et al. Diversity of leukaemic cell morphology in ATL correlates with prognostic factors, aberrant immunophenotype and defective HTLV‐1 genotype , 1999, British journal of haematology.
[115] T. Therneau,et al. Plasmablastic morphology is an independent predictor of poor survival after autologous stem-cell transplantation for multiple myeloma. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[116] P. Wollan,et al. Population‐based incidence and survival figures in essential thrombocythemia and agnogenic myeloid metaplasia: An Olmsted county study, 1976–1995 , 1999, American journal of hematology.
[117] K. Chang,et al. Frequency of CD43 expression in non-Hodgkin lymphoma. A survey of 742 cases and further characterization of rare CD43+ follicular lymphomas. , 1999, American journal of clinical pathology.
[118] O. Ottmann,et al. Megakaryocytic growth factors: is there a new approach for management of thrombocytopenia in patients with malignancies? , 1999, Leukemia.
[119] J. Thiele,et al. Focal lymphoid aggregates (nodules) in bone marrow biopsies: differentiation between benign hyperplasia and malignant lymphoma--a practical guideline. , 1999, Journal of clinical pathology.
[120] M. Slovak,et al. Acute lymphoblastic leukemia. Survey of immunophenotype, French-American-British classification, frequency of myeloid antigen expression, and karyotypic abnormalities in 210 pediatric and adult cases. , 1999, American journal of clinical pathology.
[121] P. Venugopal,et al. Biologic characteristics of patients with hypocellular myelodysplastic syndromes. , 1999, Leukemia research.
[122] J. Tooze,et al. Clonal evolution of aplastic anaemia to myelodysplasia/acute myeloid leukaemia and paroxysmal nocturnal haemoglobinuria. , 1999, Leukemia & lymphoma.
[123] J. Armitage,et al. Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[124] G. Flandrin,et al. Persistent polyclonal B lymphocytosis with binucleated lymphocytes: a study of 25 cases , 1999, British journal of haematology.
[125] G. Barosi,et al. The Italian Consensus Conference on Diagnostic Criteria for Myelofibrosis with Myeloid Metaplasia , 1999, British journal of haematology.
[126] E. Montserrat,et al. Major vascular complications in essential thrombocythemia: a study of the predictive factors in a series of 148 patients , 1999, Leukemia.
[127] C. Harrison,et al. A large proportion of patients with a diagnosis of essential thrombocythemia do not have a clonal disorder and may be at lower risk of thrombotic complications. , 1999, Blood.
[128] B. Lange,et al. Myelodysplastic and myeloproliferative disorders of childhood: a study of 167 patients. , 1999, Blood.
[129] J. Armitage. Emerging Applications of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor , 1998 .
[130] M. Slovak,et al. The immunophenotype of blast transformation of chronic myelogenous leukemia: a high frequency of mixed lineage phenotype in "lymphoid" blasts and A comparison of morphologic, immunophenotypic, and molecular findings. , 1998, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.
[131] A. Manoharan,et al. Idiopathic myelofibrosis: a clinical review. , 1998, International journal of hematology.
[132] A. Rosenwald,et al. The cytomorphological spectrum of mantle cell lymphoma is reflected by distinct biological features. , 1998, Leukemia & lymphoma.
[133] M. Borowitz,et al. Surface antigen phenotype can predict TEL-AML1 rearrangement in childhood B-precursor ALL: a Pediatric Oncology Group study , 1998, Leukemia.
[134] G. Flandrin,et al. Indolent course as a relatively frequent presentation in T‐prolymphocytic leukaemia , 1998, British journal of haematology.
[135] C. Copie-Bergman,et al. True histiocytic lymphoma: a morphologic, immunohistochemical, and molecular genetic study of 13 cases. , 1998, The American journal of surgical pathology.
[136] U. Germing,et al. Problems in the classification of CMML--dysplastic versus proliferative type. , 1998, Leukemia research.
[137] K. Lennert,et al. Diagnostic value of immunostaining for tryptase in patients with mastocytosis. , 1998, The American journal of surgical pathology.
[138] G. Avvisati,et al. Immunophenotype of adult and childhood acute promyelocytic leukaemia: correlation with morphology, type of PML gene breakpoint and clinical outcome. A cooperative Italian study on 196 cases , 1998, British journal of haematology.
[139] R. Aguiar,et al. Consistent fusion of ZNF198 to the fibroblast growth factor receptor-1 in the t(8;13)(p11;q12) myeloproliferative syndrome. , 1998, Blood.
[140] S. Shurin,et al. Pediatric Bone Marrow Cellularity: Are We Expecting Too Much? , 1998, Journal of pediatric hematology/oncology.
[141] L. Rimsza,et al. The presence of CD34+ cell clusters predicts impending relapse in children with acute lymphoblastic leukemia receiving maintenance chemotherapy. , 1998, American journal of clinical pathology.
[142] M. Tomonaga,et al. Paroxysmal nocturnal haemoglobinuria clones in patients with myelodysplastic syndromes , 1998, British journal of haematology.
[143] Farhi Dc,et al. Bone marrow biopsy findings in childhood anemia: prevalence of transient erythroblastopenia of childhood. , 1998 .
[144] K. Shannon,et al. Mutations of the NF1 gene in children with juvenile myelomonocytic leukemia without clinical evidence of neurofibromatosis, type 1. , 1998, Blood.
[145] N. Rosenthal,et al. Transient increase in blasts mimicking acute leukemia and progressing myelodysplasia in patients receiving growth factor. , 1998, American journal of clinical pathology.
[146] H. Deeg,et al. Long-term outcome after marrow transplantation for severe aplastic anemia. , 1998, Blood.
[147] F. Sigaux,et al. Inactivation of the ATM gene in T-cell prolymphocytic leukemias. , 1998, Blood.
[148] P. Cohen,et al. Bone marrow and peripheral blood involvement in mantle cell lymphoma , 1998, British journal of haematology.
[149] F. Askin,et al. Neuroblastoma and peripheral neuroectodermal tumors. , 1998, American journal of clinical pathology.
[150] R. Egeler,et al. Malignant histiocytic disorders in children. Clinical and therapeutic approaches with a nosologic discussion. , 1998, Hematology/oncology clinics of North America.
[151] C. Coffin,et al. Pathologic evaluation of pediatric soft tissue tumors. , 1998, American journal of clinical pathology.
[152] B. Klein,et al. Plasmablastic morphology--an independent prognostic factor with clinical and laboratory correlates: Eastern Cooperative Oncology Group (ECOG) myeloma trial E9486 report by the ECOG Myeloma Laboratory Group. , 1998, Blood.
[153] J. Henter,et al. Autopsy findings in 27 children with haemophagocytic lymphohistiocytosis , 1998, Histopathology.
[154] M. Salama,et al. Fluorescence in situ hybridization to assess aneuploidy for chromosomes 7 and 8 in hematologic disorders. , 1998, Cancer genetics and cytogenetics.
[155] M. Harada,et al. Bone marrow necrosis in a patient with acute myeloblastic leukemia during administration of G‐CSF and rapid hematologic recovery after allotransplantation of peripheral blood stem cells , 1998, American journal of hematology.
[156] C. Bloomfield,et al. Acute myeloid leukemia with 11q23 translocations: myelomonocytic immunophenotype by multiparameter flow cytometry , 1998, Leukemia.
[157] J. Vardiman,et al. Pseudo-Gaucher histiocytes identified up to 1 year after transplantation for CML are BCR/ABL-positive , 1998, Leukemia.
[158] L. Diehl,et al. Autoimmune disease and chronic lymphocytic leukemia: autoimmune hemolytic anemia, pure red cell aplasia, and autoimmune thrombocytopenia. , 1998, Seminars in oncology.
[159] Joseph A. DiGiuseppe,et al. Clinical utility of flow cytometry in the chronic lymphoid leukemias. , 1998, Seminars in oncology.
[160] M. Slovak,et al. The immunophenotype of adult acute myeloid leukemia: high frequency of lymphoid antigen expression and comparison of immunophenotype, French-American-British classification, and karyotypic abnormalities. , 1998, American journal of clinical pathology.
[161] N. Heerema,et al. Biology and treatment of childhood T-lineage acute lymphoblastic leukemia. , 1998, Blood.
[162] K. Maloum,et al. Basic biology of autoimmune phenomena in chronic lymphocytic leukemia. , 1998, Seminars in oncology.
[163] S. Montoto,et al. ‘Lymphoid’ blast crisis of chronic myeloid leukaemia is associated with distinct clinicohaematological features , 1998, British journal of haematology.
[164] S. Koç,et al. Sideroblastic anemias: Variations on imprecision in diagnostic criteria, proposal for an extended classification of sideroblastic anemias , 1998, American journal of hematology.
[165] A T Look,et al. Molecular Genetics of Childhood Leukemias , 1998, Journal of pediatric hematology/oncology.
[166] C. Sieff,et al. Diamond-Blackfan anemia. , 1997, Hematology/oncology clinics of North America.
[167] E. Guinan. Clinical aspects of aplastic anemia. , 1997, Hematology/oncology clinics of North America.
[168] C. Bloomfield,et al. Adult patients with de novo acute myeloid leukemia and t(9; 11)(p22; q23) have a superior outcome to patients with other translocations involving band 11q23: a cancer and leukemia group B study. , 1997, Blood.
[169] B. Leber,et al. Morphology of acute promyelocytic leukemia with cytogenetic or molecular evidence for the diagnosis: Characterization of additional microgranular variants , 1997, American journal of hematology.
[170] K. Foon,et al. U.S.-Canadian Consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: medical indications. , 1997, Cytometry.
[171] F. Behm,et al. U.S.-Canadian Consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: selection of antibody combinations. , 1997, Cytometry.
[172] P. Thall,et al. Effect of diagnosis (refractory anemia with excess blasts, refractory anemia with excess blasts in transformation, or acute myeloid leukemia [AML]) on outcome of AML-type chemotherapy. , 1997, Blood.
[173] Jennings Cd,et al. Recent Advances in Flow Cytometry: Application to the Diagnosis of Hematologic Malignancy , 1997 .
[174] R. Gascoyne,et al. U.S.-Canadian Consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: data analysis and interpretation. , 1997, Cytometry.
[175] Gregory T Stelzer,et al. U.S.-Canadian Consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: standardization and validation of laboratory procedures. , 1997, Cytometry.
[176] D. Louie,et al. Blastic natural killer cell leukemia/lymphoma: a clinicopathologic study. , 1997, The American journal of surgical pathology.
[177] K. Welte,et al. Severe chronic neutropenia: pathophysiology and therapy. , 1997, Seminars in hematology.
[178] P. Ruck,et al. Systemic mast cell disease (mastocytosis). General aspects and histopathological diagnosis. , 1997, Histology and histopathology.
[179] S. Wickramasinghe,et al. DYSERYTHROPOIESIS AND CONGENITAL DYSERYTHROPOIETIC ANAEMIAS , 1997, British journal of haematology.
[180] E. Jaffe,et al. Contemporary classification of histiocytic disorders , 1997 .
[181] J. Hoyer,et al. Immunohistochemical demonstration of acid phosphatase isoenzyme 5 (tartrate-resistant) in paraffin sections of hairy cell leukemia and other hematologic disorders. , 1997, American journal of clinical pathology.
[182] D. Oscier. Atypical chronic myeloid leukemias. , 1997, Pathologie-biologie.
[183] C. Bloomfield,et al. Expression of the neural cell adhesion molecule CD56 is associated with short remission duration and survival in acute myeloid leukemia with t(8;21)(q22;q22). , 1997, Blood.
[184] Maria Grazia Valsecchi,et al. Incidence and clinical relevance of TEL/AML1 fusion genes in children with acute lymphoblastic leukemia enrolled in the German and Italian multicenter therapy trials , 1997 .
[185] F. Facchetti,et al. Histopathological changes in bone marrow biopsies from patients with chronic myeloid leukaemia after treatment with recombinant alpha‐interferon , 1997, Histopathology.
[186] J. Snowden,et al. Cytogenetic abnormalities and their prognostic significance in idiopathic myelofibrosis: a study of 106 cases , 1997, British journal of haematology.
[187] M. Elghetany,et al. True histiocytic lymphoma: is it an entity? , 1997, Leukemia.
[188] M. Tomonaga,et al. Morphological subtyping of acute myeloid leukemia with maturation (AML-M2): homogeneous pink-colored cytoplasm of mature neutrophils is most characteristic of AML-M2 with t(8;21) , 1997, Leukemia.
[189] E. Thiel,et al. Morphological and cytochemical findings in 150 cases of T‐lineage acute lymphoblastic leukaemia in adults , 1997, British journal of haematology.
[190] L. Peterson,et al. Recurring structural chromosome abnormalities in peripheral blood lymphocytes of patients with mycosis fungoides/Sézary syndrome. , 1997, Blood.
[191] A. Órfão,et al. Sequential immunophenotypic analysis of mast cells in a case of systemic mast cell disease evolving to a mast cell leukemia. , 1997, Cytometry.
[192] R. Neiman,et al. 013 (CD99) positivity in hematologic proliferations correlates with TdT positivity. , 1997, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.
[193] C. Li,et al. Useful panel of antibodies for the classification of acute leukemia by immunohistochemical methods in bone marrow trephine biopsy specimens. , 1997, American journal of clinical pathology.
[194] T Hamblin,et al. International scoring system for evaluating prognosis in myelodysplastic syndromes. , 1997, Blood.
[195] N. Heerema,et al. Hypoplastic myelodysplastic syndromes can be distinguished from acquired aplastic anemia by CD34 and PCNA immunostaining of bone marrow biopsy specimens. , 1997, American journal of clinical pathology.
[196] D. Head,et al. Myelodysplastic syndrome in children: differentiation from acute myeloid leukemia with a low blast count , 1997, Leukemia.
[197] C. Sawyers. Molecular genetics of acute leukaemia , 1997, The Lancet.
[198] A. Florena,et al. Intrasinusoidal bone marrow infiltration: a possible hallmark of splenic lymphoma , 1996, Histopathology.
[199] G. Flandrin,et al. The value of the monoclonal antibody, DBA44, in the diagnosis of B-lymphoid disorders. , 1996, Leukemia research.
[200] S. Swerdlow,et al. Immunohistochemical characterization of mast cell disease in paraffin sections using tryptase, CD68, myeloperoxidase, lysozyme, and CD20 antibodies. , 1996, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.
[201] B. Bain. Eosinophilic leukaemias and the idiopathic hypereosinophilic syndrome. , 1996, British journal of haematology.
[202] B. Alter. Fanconi's anemia and malignancies , 1996, American journal of hematology.
[203] D. Arber,et al. Paraffin section immunophenotyping of acute leukemias in bone marrow specimens. , 1996, American journal of clinical pathology.
[204] G. Meloni,et al. Neutrophilic-chronic myeloid leukemia: a distinct disease with a specific molecular marker (BCR/ABL with C3/A2 junction) , 1996, Blood.
[205] G. Sledge,et al. Effects of recombinant human interleukin-11 (Neumega rhIL-11 growth factor) on megakaryocytopoiesis in human bone marrow. , 1996, Experimental hematology.
[206] M. Sivakumaran,et al. The clinical relevance of fluctuations in absolute-lymphocyte counts during follow-up of large granular lymphocyte proliferations [letter] , 1996 .
[207] Joseph A. DiGiuseppe,et al. Multiparameter flow-cytometric analysis of bcl-2 and Fas expression in normal and neoplastic hematopoiesis. , 1996, American journal of clinical pathology.
[208] D. Farhi,et al. Mantle cell lymphoma. Morphologic findings in bone marrow involvement. , 1996, American journal of clinical pathology.
[209] P. Morel,et al. Prognostic factors in agnogenic myeloid metaplasia: a report on 195 cases with a new scoring system. , 1996, Blood.
[210] V. Diehl,et al. Idiopathic primary osteo-myelofibrosis: a clinico-pathological study on 208 patients with special emphasis on evolution of disease features, differentiation from essential thrombocythemia and variables of prognostic impact. , 1996, Leukemia & lymphoma.
[211] J. Bennett,et al. Diagnostic criteria for hypocellular acute leukemia: a clinical entity distinct from overt acute leukemia and myelodysplastic syndrome. , 1996, Leukemia research.
[212] C. Parker. Molecular Basis of Paroxysmal Nocturnal Hemoglobinuria , 1996, Stem cells.
[213] M. Grever,et al. National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. , 1996, Blood.
[214] W. Hiddemann,et al. De novo AML with dysplastic hematopoiesis: cytogenetic and prognostic significance. , 1996, Leukemia.
[215] H. Abelson,et al. Interpretation of the complete blood count. , 1996, Pediatric clinics of North America.
[216] G. Schmitz,et al. Consensus protocol for the flow cytometric immunophenotyping of hematopoietic malignancies. Working Group on Flow Cytometry and Image Analysis. , 1996, Leukemia.
[217] Melo Jv. The molecular biology of chronic myeloid leukaemia. , 1996 .
[218] W. Stock,et al. Leukemogenic risk of hydroxyurea therapy in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis , 1996, American journal of hematology.
[219] U. Popat,et al. Idiopathic myelofibrosis in children , 1996, British journal of haematology.
[220] D. Catovsky,et al. Similarities between T-cell chronic lymphocytic leukemia and the small-cell variant of T-prolymphocytic leukemia. , 1996, Blood.
[221] S. Shin,et al. Bone marrow changes induced by recombinant granulocyte colony‐stimulating factor resembling metastatic carcinoma: Distinction with cytochemical and lmmunohistochemical studies , 1996 .
[222] S. Pittaluga,et al. Trisomy 3 in marginal zone B‐cell lymphoma: a study based on cytogenetic analysis and fluorescence in situ hybridization , 1996, British journal of haematology.
[223] B. Roald,et al. Adequacy of bone marrow trephine biopsy specimens in children. , 1996, Journal of clinical pathology.
[224] A. May,et al. The molecular basis of the sideroblastic anemias , 1996, Current opinion in hematology.
[225] A. Florena,et al. Immunophenotypical comparison of Gaucher's and pseudo‐Gaucher cells , 1996, Pathology international.
[226] D. Oscier. Atypical chronic myeloid leukaemia, a distinct clinical entitity related to the myelodysplastic syndrome? , 1996, British journal of haematology.
[227] A. Fischer,et al. Hemophagocytic lymphohistiocytosis. Report of 122 children from the International Registry. FHL Study Group of the Histiocyte Society. , 1996, Leukemia.
[228] J. Strauchen. Diagnostic Histopathology of the Bone Marrow , 1996 .
[229] A. Taylor,et al. Leukemia and lymphoma in ataxia telangiectasia. , 1996, Blood.
[230] R. Storb,et al. Relevance of marrow fibrosis in bone marrow transplantation: a retrospective analysis of engraftment. , 1995, Blood.
[231] F. Bosch,et al. Increased expression of the PRAD‐1/CCND1 gene in hairy cell leukaemia , 1995, British journal of haematology.
[232] K. Chang,et al. Pathologic features of nodular lymphocyte predominance Hodgkin's disease in extranodal sites. , 1995, The American journal of surgical pathology.
[233] J. Bennett,et al. Hypocellular myelodysplastic syndromes (MDS): new proposals , 1995, British journal of haematology.
[234] R. Aguiar,et al. A new myeloproliferative disorder associated with chromosomal translocations involving 8p11: a review. , 1995, Leukemia.
[235] H. Preisler,et al. Two in situ labeling techniques reveal different patterns of DNA fragmentation during spontaneous apoptosis in vivo and induced apoptosis in vitro. , 1995, Anticancer research.
[236] A. Orazi. CD34 immunoperoxidase staining for the diagnosis of myelodysplastic syndromes and chronic myeloid leukaemia. , 1995, Journal of Clinical Pathology.
[237] Dewald Gw,et al. Chromosome abnormalities in the myeloproliferative disorders. , 1995 .
[238] H. Preisler,et al. Apoptosis in bone marrow biopsy samples involving stromal and hematopoietic cells in 50 patients with myelodysplastic syndromes. , 1995, Blood.
[239] J Boultwood,et al. Hematological features of patients with myelodysplastic syndromes associated with a chromosome 5q deletion , 1995, American journal of hematology.
[240] P. Marynen,et al. TEL gene is involved in myelodysplastic syndromes with either the typical t(5;12)(q33;p13) translocation or its variant t(10;12)(q24;p13). , 1995, Blood.
[241] C. Wijmenga,et al. Molecular pathogenesis of the chromosome 16 inversion in the M4Eo subtype of acute myeloid leukemia. , 1995, Blood.
[242] K. Takatsuki,et al. Markedly high population of affected reticulocytes negative for decay-accelerating factor and CD59 in paroxysmal nocturnal hemoglobinuria. , 1995, Blood.
[243] E. Wattel,et al. Myelodysplastic syndromes and acute myeloid leukemia with 17p deletion. An entity characterized by specific dysgranulopoïesis and a high incidence of P53 mutations. , 1995, Leukemia.
[244] G. Sledge,et al. In vivo effects of recombinant human stem cell factor treatment. A morphologic and immunohistochemical study of bone marrow biopsies. , 1995, American Journal of Clinical Pathology.
[245] D. Catovsky,et al. The histopathology of splenic lymphoma with villous lymphocytes. , 1994, Blood.
[246] N. Rosenthal,et al. Failure to engraft after bone marrow transplantation: bone marrow morphologic findings. , 1994, American journal of clinical pathology.
[247] J. Boultwood,et al. The 5q-syndrome. , 1994, Blood.
[248] G. Karayalcin,et al. Transient erythroblastopenia of childhood. Prospective study of fifty patients. , 1994, The American journal of pediatric hematology/oncology.
[249] G. Cattoretti,et al. Terminal deoxynucleotidyl transferase staining in acute leukemia and normal bone marrow in routinely processed paraffin sections. , 1994, American journal of clinical pathology.
[250] R. Papac. Bone marrow metastases. A review , 1994, Cancer.
[251] H. Murakami,et al. Myelodysplastic syndrome with bone marrow eosinophilia: clinical and cytogenetic features. , 1994, Leukemia & lymphoma.
[252] D. Catovsky,et al. Persistent polyclonal B-cell lymphocytosis. , 1994, Leukemia research.
[253] H. Gralnick,et al. The chronic myeloid leukaemias: guidelines for distinguishing chronic granulocytic, atypical chronic myeloid, and chronic myelomonocytic leukaemia: Proposals by the French ‐ American ‐ British Cooperative Leukaemia Group , 1994, British journal of haematology.
[254] W. Franklin,et al. Bone marrow involvement by lobular carcinoma of the breast cannot be identified reliably by routine histological examination alone. , 1994, Human pathology.
[255] Harris Ac,et al. Bone marrow changes associated with recombinant granulocyte-macrophage and granulocyte colony-stimulating factors. Discrimination of granulocytic regeneration. , 1994, Archives of Pathology & Laboratory Medicine.
[256] A. Cortelezzi,et al. CD34 immunohistochemistry of bone marrow biopsies: Prognostic significance in primary myelodysplastic syndromes , 1994, American journal of hematology.
[257] G. Gahrton,et al. Hairy cell leukemia is characterized by clonal chromosome abnormalities clustered to specific regions. , 1994, Blood.
[258] Todd R. Golub,et al. Fusion of PDGF receptor β to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation , 1994, Cell.
[259] N. Heerema,et al. CD34 immunostaining of bone marrow biopsy specimens is a reliable way to classify the phases of chronic myeloid leukemia. , 1994, American journal of clinical pathology.
[260] L. Dreosti,et al. Bone marrow necrosis following ALL-trans retinoic acid therapy for acute promyelocytic leukaemia. , 1994, Leukemia and Lymphoma.
[261] J. Tanzer. Clonality and karyotype studies in polycythemia vera. , 1994, Nouvelle revue francaise d'hematologie.
[262] D. Arthur,et al. L3 acute lymphoblastic leukemia. Comparison with small noncleaved cell lymphoma involving the bone marrow. , 1994, American journal of clinical pathology.
[263] K. Ohshima,et al. Bone marrow findings in malignant histiocytosis and/or malignant lymphoma with concurrent hemophagocytic syndrome. , 1993, Leukemia & lymphoma.
[264] H. Tilly,et al. Therapy-related acute myeloid leukemia with t(8;21), inv(16), and t(8;16): a report on 25 cases and review of the literature. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[265] S. Larsen,et al. Therapy-related myelodysplasia and acute myeloid leukemia. Cytogenetic characteristics of 115 consecutive cases and risk in seven cohorts of patients treated intensively for malignant diseases in the Copenhagen series. , 1993, Leukemia.
[266] M. Borowitz,et al. Immunophenotyping of acute leukemia by flow cytometric analysis. Use of CD45 and right-angle light scatter to gate on leukemic blasts in three-color analysis. , 1993, American journal of clinical pathology.
[267] D. Jones,et al. Haemopoietic regrowth after chemotherapy for acute leukaemia: an immunohistochemical study of bone marrow trephine biopsy specimens. , 1993, Journal of clinical pathology.
[268] L. Van Hove,et al. Recommended procedures for the classification of acute leukaemias. International Council for Standardization in Haematology (ICSH). , 1993, Leukemia & lymphoma.
[269] B. Helbert,et al. The bone marrow agar section: a morphologic and immunohistochemical evaluation. , 1993, Modern Pathology.
[270] Z. Estrov,et al. Chronic neutropenia of childhood: frequent association with parvovirus infection and correlations with bone marrow culture studies , 1993, British journal of haematology.
[271] M. Lishner,et al. A comparative analysis of alkylating agent and epipodophyllotoxin-related leukemias. , 1993, Leukemia & lymphoma.
[272] N. Heerema,et al. Frequent p53 overexpression in therapy related myelodysplastic syndromes and acute myeloid leukemias: an immunohistochemical study of bone marrow biopsies. , 1993, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.
[273] S. Steinberg,et al. Prognostic implications of a bone marrow histopathologic classification system in mycosis fungoides and the Sézary syndrome , 1993, Cancer.
[274] T. Loughran,et al. Clonal diseases of large granular lymphocytes. , 1993, Blood.
[275] N. Heerema,et al. Hematopoietic precursor cells within the yolk sac tumor component are the source of secondary hematopoietic malignancies in patients with mediastinal germ cell tumors , 1993 .
[276] G. Cattoretti,et al. Therapy-related myelodysplastic syndromes: FAB classification, bone marrow histology, and immunohistology in the prognostic assessment. , 1993, Leukemia.
[277] Koichi Sugimoto,et al. Mutations of the p53 gene in myelodysplastic syndrome (MDS) and MDS-derived leukemia. , 1993, Blood.
[278] P. Benn,et al. Review of the cytogenetic changes in acute megakaryoblastic leukemia: one disease or several? , 1993, Cancer genetics and cytogenetics.
[279] Teizo Fujita,et al. Deficiency of the GPI anchor caused by a somatic mutation of the PIG-A gene in paroxysmal nocturnal hemoglobinuria , 1993, Cell.
[280] K. Gatter,et al. The bone marrow trephine biopsy: a review of normal histology , 1993, Histopathology.
[281] M. Colombo,et al. Bone marrow stroma in humans: anti-nerve growth factor receptor antibodies selectively stain reticular cells in vivo and in vitro , 1993 .
[282] K. Mainzer,et al. Hypoplastic myelodysplastic syndrome: incidence, morphology, cytogenetics, and prognosis , 1993, Annals of Hematology.
[283] J. Michelson,et al. Bone morphology after bone marrow transplantation for Hodgkin's and non-Hodgkin's lymphoma. , 1993, Experimental hematology.
[284] S. Bentley,et al. Bone marrow histiocytic proliferation in association with colony-stimulating factor therapy. , 1993, American journal of clinical pathology.
[285] T. McCurley,et al. Differentiation of reactive from neoplastic small-cell lymphoid aggregates in paraffin-embedded marrow particle preparations using L-26 (CD20) and UCHL-1 (CD45RO) monoclonal antibodies. , 1993, American journal of clinical pathology.
[286] K. McNally,et al. Audit of bone marrow trephines. , 1992, Journal of clinical pathology.
[287] P. Watkins,et al. Transcriptionally active chimeric gene derived from the fusion of the AML1 gene and a novel gene on chromosome 8 in t(8;21) leukemic cells. , 1992, Cancer genetics and cytogenetics.
[288] E. Jaffe,et al. Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma With Reed-Sternberg–Like Cells and Possible Transformation to Hodgkin's Disease: Mediation by Epstein-Barr Virus , 1992, The American journal of surgical pathology.
[289] R. Luksch,et al. Incidence and histological features of bone marrow involvement in malignant lymphomas , 1992, Annals of Hematology.
[290] D. Weisenburger,et al. Systemic polyclonal B-immunoblastic proliferation with marked peripheral blood and bone marrow plasmacytosis. , 1992, American journal of clinical pathology.
[291] T. Kyo,et al. Phenotypical characteristics of acute myelocytic leukemia associated with the t(8;21)(q22;q22) chromosomal abnormality: frequent expression of immature B-cell antigen CD19 together with stem cell antigen CD34. , 1992, Blood.
[292] T. Lion,et al. The translocation t(1;22)(p13;q13) is a nonrandom marker specifically associated with acute megakaryocytic leukemia in young children , 1992 .
[293] G. Cattoretti,et al. Recombinant human interleukin-3 and recombinant human granulocyte-macrophage colony-stimulating factor administered in vivo after high-dose cyclophosphamide cancer chemotherapy: effect on hematopoiesis and microenvironment in human bone marrow. , 1992, Blood.
[294] H. Lazarus,et al. Bone marrow and blood findings after marrow transplantation and rhGM-CSF therapy. , 1992, American journal of clinical pathology.
[295] K. Chang,et al. Hairy cell leukemia. Current status. , 1992, American journal of clinical pathology.
[296] S. Robboy,et al. The gelatinous bone marrow (serous atrophy) in patients with acquired immunodeficiency syndrome. Evidence of excess sulfated glycosaminoglycan. , 1992, Archives of pathology & laboratory medicine.
[297] N. Kamada,et al. Chromosome abnormalities in adult T-cell leukemia/lymphoma: a karyotype review committee report. , 1992, Cancer research.
[298] A. Boyd,et al. Marrow proliferation and the appearance of giant neutrophils in response to recombinant human granulocyte colony stimulating factor (rhG‐CSF) , 1992, British journal of haematology.
[299] J. Drach,et al. The biological and clinical significance of the KI‐67 growth fraction in multiple myeloma , 1992, Hematological oncology.
[300] J. Denburg. Basophil and Mast Cell Lineages In Vitro and In Vivo , 1992 .
[301] L. Penchansky,et al. Morphological diagnosis of parvovirus B19 infection. A cytopathic effect easily recognized in air-dried, formalin-fixed bone marrow smears stained with hematoxylin-eosin or Wright-Giemsa. , 1992, Archives of pathology & laboratory medicine.
[302] D. Catovsky,et al. Clinical and laboratory features of 78 cases of T-prolymphocytic leukemia. , 1991, Blood.
[303] A. Vora,et al. POLYCLONAL CD5+ B‐LYMPHOCYTOSIS RESEMBLING CHRONIC LYMPHOCYTIC LEUKAEMIA , 1991, British Journal of Haematology.
[304] H. Gralnick,et al. Proposal for the recognition of minimally differentiated acute myeloid leukaemia (AML‐MO) , 1991, British journal of haematology.
[305] P. Martiat,et al. Philadelphia-negative (Ph-) chronic myeloid leukemia (CML): comparison with Ph+ CML and chronic myelomonocytic leukemia. The Groupe Français de Cytogénétique Hématologique. , 1991, Blood.
[306] D. LeBrun,et al. Essential thrombocythemia with the Philadelphia chromosome and BCR-ABL gene rearrangement. An entity distinct from chronic myeloid leukemia and Philadelphia chromosome-negative essential thrombocythemia. , 1991, Cancer genetics and cytogenetics.
[307] R. Brunning,et al. The morphologic and immunophenotypic assessment of the lymphocytosis accompanying Bordetella pertussis infection. , 1991, American journal of clinical pathology.
[308] R. Luksch,et al. Myelodysplastic syndrome with increased marrow fibrosis: a distinct clinico‐pathological entity , 1991, British journal of haematology.
[309] J. Brockschmidt,et al. Bone marrow and peripheral blood findings in patients with extreme thrombocytosis. A report of 63 cases. , 1991, Archives of pathology & laboratory medicine.
[310] W. Velasquez,et al. Discordant bone marrow involvement in diffuse large-cell lymphoma: a distinct clinical-pathologic entity associated with a continuous risk of relapse. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[311] Y. Neuman,et al. Atypical chronic myelomonocytic leukemia with eosinophilia and translocation (5;12). A new association. , 1991, Cancer genetics and cytogenetics.
[312] Ó. Jónsson,et al. Chronic neutropenia during childhood. A 13-year experience in a single institution. , 1991, American journal of diseases of children.
[313] Beckman En,et al. Normal reticulin level in iliac bone marrow. , 1990 .
[314] D. Rosenthal,et al. Chronic myelomonocytic leukemia. , 1990, Leukemia.
[315] W. Chuu,et al. Primary myelofibrosis in children: report of 4 cases. , 1990, Journal of the Formosan Medical Association = Taiwan yi zhi.
[316] R. Warnke,et al. Malignant histiocytosis a reassessment of cases previously reported in 1975 based on paraffin section immunophenotyping studies , 1990, Cancer.
[317] D. Snyder,et al. Treatment of chronic myelogenous leukemia with bone marrow transplantation. , 1990, Hematology/oncology clinics of North America.
[318] P. Kluin,et al. Early reconstitution of haematopoiesis after allogeneic bone marrow transplantation: a prospective histopathological study of bone marrow biopsy specimens. , 1990, Journal of clinical pathology.
[319] X. Thomas,et al. Myelodysplastic syndromes: A study of surface markers and in vitro growth patterns , 1990, American journal of hematology.
[320] F. Davey,et al. Immunophenotyping of acute leukemias using paraffin-embedded tissue sections. , 1990, American journal of clinical pathology.
[321] J. Greer,et al. Marrow involvement in cutaneous T-cell lymphoma. A clinicopathologic study of 60 cases. , 1989, American journal of clinical pathology.
[322] P. Kluin,et al. Histopathology of bone marrow reconstitution after allogeneic bone marrow transplantation , 1989, Histopathology.
[323] K. Foucar,et al. Peripheral blood morphologic changes after high-dose antineoplastic chemotherapy and recombinant human granulocyte colony-stimulating factor administration. , 1989, American journal of clinical pathology.
[324] N. Nagahara,et al. Granulocytosis associated with malignant neoplasms: a clinicopathologic study and demonstration of colony-stimulating activity in tumor extracts. , 1989, Human pathology.
[325] H. Gralnick,et al. Proposals for the classification of chronic (mature) B and T lymphoid leukaemias. French-American-British (FAB) Cooperative Group. , 1989, Journal of clinical pathology.
[326] D. Layton,et al. Myelofibrosis in primary myelodysplastic syndromes: a clinico‐morphological study of 10 cases , 1989, British journal of haematology.
[327] T. McConnell,et al. Hematogones: a multiparameter analysis of bone marrow precursor cells. , 1989, Blood.
[328] B. Hyun,et al. Structure and function of the bone marrow and hematopoiesis. , 1988, Hematology/oncology clinics of North America.
[329] Buckner Cd,et al. Pathology of Bone Marrow in Transplant Recipients , 1988 .
[330] R. Beuscart,et al. Prognostic factors in adult chronic myelomonocytic leukemia: an analysis of 107 cases. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[331] J. Guerra-Vales,et al. Significance of granulomas in bone marrow: A study of 40 cases , 1988, European journal of haematology.
[332] C. Hess,et al. Promyelocyte morphology. Differentiation of acute promyelocytic leukemia from benign myeloid proliferations. , 1987, American journal of clinical pathology.
[333] J. Melo,et al. Cytogenetic studies on prolymphocytic leukemia. 1. B-cell prolymphocytic leukemia. , 1987, Hematologic pathology.
[334] C. Li,et al. Radiological features of systemic mast-cell disease. , 1987, The British journal of radiology.
[335] E. Sausville,et al. Evaluation of circulating malignant cells provides prognostic information in cutaneous T cell lymphoma , 1987 .
[336] Koji Saito,et al. HEPATITIS‐ASSOCIATED APLASTIC ANEMIA WITH SYSTEMIC PLASMACYTOSIS , 1987, Acta pathologica japonica.
[337] R. Larson,et al. Acute myelomonocytic leukemia with abnormal eosinophils and inv(16) or t(16;16) has a favorable prognosis. , 1986, Blood.
[338] J. Montaner,et al. Absolute lymphocytosis associated with nonsurgical trauma. , 1986, American journal of clinical pathology.
[339] G. Tricot,et al. The histological characterization of ALIP in the myelodysplastic syndromes. , 1986, Pathology, research and practice.
[340] R. Neiman,et al. Bone marrow morphology and immunology in systemic amyloidosis. , 1986, American journal of clinical pathology.
[341] G Flandrin,et al. Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group. , 1985, Annals of internal medicine.
[342] J. Srigley,et al. Q-Fever: The liver and bone marrow pathology , 1985, The American journal of surgical pathology.
[343] D. Catovsky,et al. Criteria for the diagnosis of acute leukemia of megakaryocyte lineage (M7). A report of the French-American-British Cooperative Group. , 1985, Annals of internal medicine.
[344] K. Lennert,et al. Bone marrow findings in systemic mastocytosis. , 1985, Human pathology.
[345] P. Nowell,et al. Diagnostic and prognostic significance of Sézary cells in peripheral blood smears from patients with cutaneous T cell lymphoma. , 1985, Blood.
[346] H. Kantarjian,et al. A characteristic pattern of leukemic cell differentiation without cytoreduction during remission induction in acute promyelocytic leukemia. , 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[347] D. Arthur,et al. Therapy-related acute myeloid leukemia and myelodysplastic syndrome: a clinical and morphologic study of 65 cases. , 1985, Blood.
[348] D. Mccarthy. FIBROSIS OF THE BONE MARROW: CONTENT AND CAUSES , 1985, British journal of haematology.
[349] R. Brunning,et al. Bacteria‐associated hemophagocytic syndrome , 1984, Cancer.
[350] J. Melo,et al. Hairy cell leukemia (HCL) variant: an intermediate disease between HCL and B prolymphocytic leukemia. , 1984, Seminars in oncology.
[351] D. Catovsky,et al. Bone marrow fibre content in acute myeloid leukaemia before and after treatment. , 1984, Journal of clinical pathology.
[352] E. Montserrat,et al. Bone marrow histologic pattern--the best single prognostic parameter in chronic lymphocytic leukemia: a multivariate survival analysis of 329 cases. , 1984, Blood.
[353] E. Jaffe,et al. The pathologic spectrum of adult T‐cell leukemia/lymphoma in the United States: Human T‐cell leukemia/lymphoma virus‐associated lymphoid malignancies , 1984, The American journal of surgical pathology.
[354] M. Gallivan,et al. Carcinocythemia (carcinoma cell leukemia). Report of two cases with english literature review , 1984, Cancer.
[355] B. Hamory,et al. Granulomatous Bone Marrow Disease: A REVIEW OF THE LITERATURE AND CLINICOPATHOLOGIC ANALYSIS OF 58 CASES , 1983, Medicine.
[356] R. Larson,et al. Association of an inversion of chromosome 16 with abnormal marrow eosinophils in acute myelomonocytic leukemia. A unique cytogenetic-clinicopathological association. , 1983, The New England journal of medicine.
[357] N. C. Yu,et al. Granulomatous lesions of the bone marrow in non-Hodgkin's lymphoma. , 1982, Human pathology.
[358] H. Gralnick,et al. Proposals for the classification of the myelodysplastic syndromes , 1982, British journal of haematology.
[359] H. Gruber,et al. Diagnosis of bone disease by core biopsies. , 1981, Seminars in hematology.
[360] R. Brunning,et al. Virus associated hemophagocytic syndrome. , 1981, Human pathology.
[361] H. Gralnick,et al. The Morphological Classification of Acute Lymphoblastic Leukaemia: Concordance among Observers and Clinical Correlations , 1981, British journal of haematology.
[362] S. Blum,et al. Thrombocytopenia with decreased megakaryocytes. Evaluation and prognosis. , 1981, Annals of internal medicine.
[363] H. Mugishima,et al. AGNOGENIC MYELOFIBROSIS IN CHILDREN , 1981 .
[364] S. Stass,et al. Value of imprint preparations of bone marrow biopsies in hematologic diagnosis , 1980, Cancer.
[365] M. Westerman,et al. An evaluation of cellularity in various types of bone marrow specimens. , 1979, American journal of clinical pathology.
[366] A. Manoharan,et al. The Reticulin Content of Bone Marrow in Acute Leukaemia in Adults , 1979, British journal of haematology.
[367] P. Bullough,et al. The pathophysiology of bone and joint disease. , 1979, The American journal of pathology.
[368] R. Storb,et al. A prospective study of androgens and bone marrow transplantation for treatment of severe aplastic anemia. , 1979, Blood.
[369] A. Linker,et al. Gelatinous transformation of the bone marrow. , 1978, Human pathology.
[370] R. Brynes,et al. Bone marrow aspiration and trephine biopsy. An approach to a thorough study. , 1978, American journal of clinical pathology.
[371] B. Drewinko,et al. Frequency and significance of bone marrow involvement by metastatic solid tumors , 1977, Cancer.
[372] H. Gralnick,et al. Proposals for the Classification of the Acute Leukaemias French‐American‐British (FAB) Co‐operative Group , 1976, British journal of haematology.
[373] C. Bloomfield,et al. Bilateral trephine bone marrow biopsies in lymphoma and other neoplastic diseases. , 1975, Annals of internal medicine.
[374] M. Adachi,et al. The pathology of sphingolipidoses. , 1972, Seminars in hematology.
[375] A. Rywlin,et al. Lipid granulomas of the bone marrow. , 1972, American journal of clinical pathology.
[376] C. Li,et al. Tartrate-resistant acid phosphatase isoenzyme in the reticulum cells of leukemic reticuloendotheliosis. , 1971, The New England journal of medicine.
[377] S. Donaldson,et al. Isolated granulomas in Hodgkin's disease. , 1970, The New England journal of medicine.
[378] C. Pearson,et al. AZATHIOPRINE AND PREDNISONE IN THE TREATMENT OF ADULTS WITH LUPUS NEPHRITIS: CLINICAL HISTOLOGICAL, IMMUNOLOGICAL CHANGES WITH THERAPY , 1970, Medicine.
[379] V. McKusick,et al. THROMBOCYTOPENIA WITH ABSENT RADIUS (TAR) , 1969, Medicine.
[380] C S PETTY,et al. NORMAL VARIATIONS WITH AGING OF THE AMOUNT OF HEMATOPOIETIC TISSUE IN BONE MARROW FROM THE ANTERIOR ILIAC CREST. A STUDY MADE FROM 177 CASES OF SUDDEN DEATH EXAMINED BY NECROPSY. , 1965, American journal of clinical pathology.
[381] Maldonado Je,et al. MONOCYTOSIS: A CURRENT APPRAISAL. , 1965 .
[382] D. Pinkel,et al. BONE MARROW ASPIRATION IN CHILDREN WITH MALIGNANT TUMORS. , 1964, The Journal of pediatrics.
[383] T. Bothwell,et al. The quantitative estimation of total iron stores in human bone marrow. , 1963, The Journal of clinical investigation.
[384] H. Broman,et al. The application of the Prussian blue stain to previously stained films of blood and bone marrow. , 1955, Blood.
[385] B. Bain,et al. Bone Marrow Pathology , 1949 .
[386] D. Huhn,et al. Acute parvovirus B19 infection mimicking myelodysplastic syndrome of the bone marrow , 2005, Annals of Hematology.
[387] J. Thiele,et al. Diagnostic impact of bone marrow histopathology in polycythemia vera (PV). , 2005, Histology and histopathology.
[388] J. D. van der Walt,et al. European consensus on grading bone marrow fibrosis and assessment of cellularity. , 2005, Haematologica.
[389] L. Bullinger,et al. Genetics of chronic lymphocytic leukemia: genomic aberrations and VH gene mutation status in pathogenesis and clinical course , 2002, Leukemia.
[390] A. Tefferi,et al. Distinct bone marrow findings in T-cell granular lymphocytic leukemia revealed by paraffin section immunoperoxidase stains for CD8, TIA-1, and granzyme B. , 2002, Blood.
[391] O. Haas,et al. Treatment of chronic myelogenous leukemia with the tyrosine kinase inhibitor STI571 results in marked regression of bone marrow fibrosis. , 2002, Blood.
[392] F. Mertens,et al. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Soft Tissue and Bone , 2002 .
[393] J. Prchal. Pathogenetic mechanisms of polycythemia vera and congenital polycythemic disorders. , 2001, Seminars in hematology.
[394] M. Ballmaier,et al. c-mpl mutations are the cause of congenital amegakaryocytic thrombocytopenia. , 2001, Blood.
[395] T. Pearson. Evaluation of diagnostic criteria in polycythemia vera. , 2001, Seminars in hematology.
[396] H M Kvasnicka,et al. Relevance of bone marrow features in the differential diagnosis between essential thrombocythemia and early stage idiopathic myelofibrosis. , 2000, Haematologica.
[397] R. Brand,et al. Treatment of acquired severe aplastic anemia: bone marrow transplantation compared with immunosuppressive therapy--The European Group for Blood and Marrow Transplantation experience. , 2000, Seminars in hematology.
[398] Y. Saunthararajah,et al. Myelodysplastic syndrome and aplastic anemia: distinct entities or diseases linked by a common pathophysiology? , 2000, Seminars in hematology.
[399] J. Thiele,et al. Thrombozytose versus Thrombozythämie – zur Differentialdiagnose des erhöhten Plättchenwertes , 2000, Der Pathologe.
[400] F. Facchetti,et al. Expression of CD34 by megakaryocytes in myelodysplastic syndromes. , 2000, Haematologica.
[401] D. Longo,et al. T-small lymphocyte disorders. , 1999, Seminars in hematology.
[402] S. Murphy. Diagnostic criteria and prognosis in polycythemia vera and essential thrombocythemia. , 1999, Seminars in hematology.
[403] Gerard E. Dallal,et al. False-negative rates of tumor metastases in the histologic examination of bone marrow. , 1999, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.
[404] Peter Lichter,et al. Chromosome aberrations in B-cell chronic lymphocytic leukemia: reassessment based on molecular cytogenetic analysis , 1999, Journal of Molecular Medicine.
[405] J. Lazarchick,et al. Systemic mast cell disease with marrow and splenic involvement associated with chronic myelomonocytic leukemia. , 1999, Leukemia & lymphoma.
[406] G. Dewald,et al. Acute myeloid leukemia with minimal differentiation. A multiple parameter study. , 1998, American journal of clinical pathology.
[407] D. Pinkel. Differentiating juvenile myelomonocytic leukemia from infectious disease. , 1998, Blood.
[408] D. Soligo,et al. The diagnostic and prognostic value of bone marrow immunostaining in myelodysplastic syndromes. , 1998, Leukemia & lymphoma.
[409] R. Zambello,et al. Large granular lymphocytosis. , 1998, Haematologica.
[410] T. Hudson,et al. FGFR1 is fused with a novel zinc-finger gene, ZNF198, in the t(8;13) leukaemia/lymphoma syndrome , 1998, Nature Genetics.
[411] M. Slovak,et al. Presence of t(8;21)(q22;q22) in myeloperoxidase-positive, myeloid surface antigen-negative acute myeloid leukemia. , 1997, American journal of clinical pathology.
[412] Brown Ke,et al. Parvovirus B19 in human disease. , 1997 .
[413] J. Laszlo,et al. Experience of the Polycythemia Vera Study Group with essential thrombocythemia: a final report on diagnostic criteria, survival, and leukemic transition by treatment. , 1997, Seminars in hematology.
[414] M. Caligiuri,et al. Developments in cytogenetics and oncogenes in acute leukemia. , 1997, Current opinion in oncology.
[415] M. Kahsai,et al. p53 overexpression in myeloid leukemic disorders is associated with increased apoptosis of hematopoietic marrow cells and ineffective hematopoiesis. , 1996, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.
[416] R. Larson,et al. Refractory cytopenia with multilineage dysplasia: further characterization of an 'unclassifiable' myelodysplastic syndrome. , 1996, Leukemia.
[417] J. Holland,et al. Analysis of myeloid and lymphoid markers on the surface and in the cytoplasm of mononuclear bone marrow cells in patients with myelodysplastic syndrome. , 1996, Journal of clinical & laboratory immunology.
[418] N. Harris,et al. CD5+ extranodal marginal zone B-cell (MALT) lymphoma. A low grade neoplasm with a propensity for bone marrow involvement and relapse. , 1996, American journal of clinical pathology.
[419] S. Wolff,et al. Ringed sideroblasts: a frequent observation after bone marrow transplantation. , 1995, Modern Pathology.
[420] L. Van Hove,et al. Recommended procedures for the classification of acute leukaemias. , 1995, Leukemia & lymphoma.
[421] H. Löffler,et al. Acute megakaryoblastic leukemia. , 1995, Leukemia & lymphoma.
[422] D. Weisdorf,et al. Morphologic and quantitative changes in blood and marrow cells following growth factor therapy. , 1994, American journal of clinical pathology.
[423] D. Catovsky,et al. The immunophenotype of hairy cell leukemia (HCL). Proposal for a scoring system to distinguish HCL from B-cell disorders with hairy or villous lymphocytes. , 1994, Leukemia & lymphoma.
[424] M. Goulian,et al. Bone marrow fibrin ring granulomas and cytomegalovirus infection. , 1993, American journal of clinical pathology.
[425] K. Wong,et al. Solid tumour with initial presentation in the bone marrow—a clinicopathologic study of 25 adult cases , 1993, Hematological oncology.
[426] F. Behm,et al. Acute megakaryoblastic leukemia in children and adolescents: a retrospective analysis of 24 cases. , 1993, Leukemia & lymphoma.
[427] K. Ohshima,et al. Pathology of adult T-cell leukemia/lymphoma and HTLV-I associated organopathies , 1992 .
[428] F. Naeim. Pathology of bone marrow , 1992 .
[429] H. Preisler,et al. Expression of hematopoietic progenitor cell associated antigen CD34 in chronic myeloid leukemia. , 1991, Leukemia research.
[430] G. Cattoretti,et al. A case of chronic neutrophilic leukemia with trisomy 8. , 1989, Acta haematologica.
[431] D. Farhi. Germinal centers in the bone marrow. , 1989, Hematologic pathology.
[432] D. C. Farhi,et al. Bone marrow granulomas: clinicopathologic findings in 72 cases and review of the literature. , 1988, Hematologic pathology.
[433] P. Banks,et al. Splenic hematopoiesis in polycythemia vera. A morphologic and immunohistologic study. , 1988, American journal of clinical pathology.
[434] J. Parkin,et al. Transient atypical lymphocytosis in patients with emergency medical conditions. , 1987, Archives of pathology & laboratory medicine.
[435] M. Boccadoro,et al. Reactive plasmacytosis. Case report and review of the literature. , 1985, Acta haematologica.
[436] K. Lennert,et al. Pathology of the bone marrow , 1984 .
[437] C. Kittas,et al. Patterns of bone marrow involvement in chronic lymphocytic leukemia and small lymphocytic (well differentiated) non‐hodgkin's lymphoma. Its clinical significance in relation to their differential diagnosis and prognosis , 1984, Cancer.
[438] H. Mugishima,et al. Agnogenic myelofibrosis in children--a case report and review of the literature. , 1981, Acta pathologica japonica.
[439] Herbert Begemann,et al. Atlas of Clinical Hematology , 1979, Springer Berlin Heidelberg.
[440] S. Granger,et al. Bone marrow cellularity determination: comparison of the biopsy, aspirate, and buffy coat , 1977 .
[441] R. Griggs. LEAD POISONING: HEMATOLOGIC ASPECTS. , 1964, Progress in hematology.